We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Treatment With Oxymorphone Is Patent-Eligible, Panel Says

Mealey's (April 2, 2019, 1:33 PM EDT) -- WASHINGTON, D.C. — In a March 28 ruling, the Federal Circuit U.S. Court of Appeals found that a Delaware federal judge incorrectly deemed a method of administering controlled release oxymorphone to...
To view the full article, register now.